Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Journal: American journal of hematology
Published: June 25, 2026
Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.
Journal: JCO global oncology
Published: May 29, 2026
Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adults.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 01, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.
Journal: Blood cancer journal
Published: March 13, 2026
The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review.
Journal: Exploration of targeted anti-tumor therapy
Published: November 29, 2025
Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 18, 2025
[177Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive Review.
Journal: Seminars in nuclear medicine
Published: May 30, 2025
Lung Cancer in Jordan.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 12, 2025
Aggressive ductal carcinoma presented with bilateral breast superscan on [18F]FDG PET/CT.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: April 03, 2025
Bridging borders for resilience in cancer control in the Middle East: a strategic alliance of Saudi Arabia, Qatar, and Jordan.
Journal: The Lancet. Oncology
Published: December 22, 2024
The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.
Journal: Cancers
Published: November 24, 2024
Last Updated: 09/26/2026